1.   Barr is confident that its generic estrogen will hit the market and win acceptance among women.

2.   Barr remains committed to developing a generic estrogen, according to CEO Bruce Downey.

3.   Both companies vowed to continue their quest to win FDA approval of generic estrogens.

4.   Duramed and Barr included only the five effective components in their generic estrogen products.

5.   In a statement, Duramed also said it would consider all options to win approval of its generic estrogen.

6.   Last week, FDA officials said generic estrogen manufacturers have to be able to show which ingredients make Premarin effective in order to show they have the same benefits.